日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia

ASXL1 突变预示慢性粒细胞白血病对尼洛替尼治疗的分子反应较差

Lioba Schönfeld #, Jenny Rinke #, Anna Hinze, Saskia N Nagel, Vivien Schäfer, Thomas Schenk, Christian Fabisch, Tim H Brümmendorf, Andreas Burchert, Philipp le Coutre, Stefan W Krause, Susanne Saussele, Fatemeh Safizadeh, Markus Pfirrmann, Andreas Hochhaus, Thomas Ernst

Potential risk groups and psychological, psychosocial, and health behavioral predictors of pharmacological neuroenhancement among university students in Germany

德国大学生药物神经增强的潜在风险群体及其心理、社会心理和健康行为预测因素

Heller, Sebastian; Tibubos, Ana Nanette; Hoff, Thilo A; Werner, Antonia M; Reichel, Jennifer L; Mülder, Lina M; Schäfer, Markus; Pfirrmann, Daniel; Stark, Birgit; Rigotti, Thomas; Simon, Perikles; Beutel, Manfred E; Letzel, Stephan; Dietz, Pavel

Antecedents and Moderation Effects of Maladaptive Coping Behaviors Among German University Students

德国大学生不良应对行为的前因及调节效应

Mülder, Lina Marie; Deci, Nicole; Werner, Antonia Maria; Reichel, Jennifer L; Tibubos, Ana Nanette; Heller, Sebastian; Schäfer, Markus; Pfirrmann, Daniel; Edelmann, Dennis; Dietz, Pavel; Beutel, Manfred E; Letzel, Stephan; Rigotti, Thomas

PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells

PTPRG 和 PTPRC 调节慢性粒细胞白血病细胞对尼洛替尼的反应

Julia Drube, Thomas Ernst, Markus Pfirrmann, Benadict Vincent Albert, Sebastian Drube, Daniela Reich, Anne Kresinsky, Kathrin Halfter, Claudio Sorio, Christian Fabisch, Andreas Hochhaus, Frank-D Böhmer